Cointime

Download App
iOS & Android

The Use of Blockchain to Fight Drug Counterfeiting in the Pharmaceutical Industry

Drug counterfeiting is a huge problem worldwide. The prevalence of counterfeit drugs is especially problematic in emerging markets, where regulatory controls are often lax, and the demand for cheap medicines is high.

In fact, it is estimated that counterfeit drugs make up 10% of the global market, costing the industry billions of dollars each year. Despite pharmaceutical companies’ best efforts, the booming counterfeiting market is always prepared to outsmart them in a game of cat and mouse. Keeping tabs on suppliers and verifying authentic supply chains has become quite challenging.

From lax regulation to global trends, the challenges of counterfeit drugs are ever evolving. The pharmaceutical industry feels this impact as healthcare costs rise worldwide; drug counterfeiting could soon become an epidemic if anti-counterfeit strategies aren’t implemented quickly and effectively. As globalization continues to open new markets with increased demand for pharmaceuticals, we must intervene before these nefarious practices spiral out of control.

But what if there were a way to fight back against these counterfeiters? That’s where blockchain comes in.

Infusing Blockchain in the Pharmaceutical Industry

The health sector has been abuzz with the news of blockchain technology coming to revolutionize pharmaceuticals — and its potential continues to drive widespread excitement as trials continue.

Blockchain technology is the ultimate data protector, offering a foolproof system against malicious hacking and corruption. Its decentralized network uses a secure sharing protocol so only authorized parties can access valuable information about products throughout their entire supply chain journey — from origin to consumer — ensuring that drugs stay safe in transit.

Blockchain is an Ideal Technology for Pharmaceutical Track and Trace

Blockchain is shaking up healthcare, allowing drug manufacturers to create a secure ecosystem where data security and quality are top-notch. Everyone involved can easily access the necessary information — never before has it been so easy or promising for healthcare professionals to benefit from such a revolutionary technology.

With the addition of serial numbers to a blockchain, products get an unchanging identity. This is then kept safe through two hallmarks of blocks — decentralization and checksums. Firstly, all involved parties must sign off on any changes made while heightened levels of accuracy are enabled by cryptographic hash functions that mean alterations can never be reversed.

This platform provides a safe and secure way to get pharmaceuticals and carry out transactions. Buyers, sellers, manufacturers — everyone can experience an expedited process free from unnecessary intermediaries. Traceability is guaranteed, so you won’t have to worry about unexpected changes.

Data Security

Blockchain technology provides a safe haven for safeguarding patients’ medical records. It keeps the data secure and grants only those with permission access to confidential information, ensuring people’s rights aren’t compromised. In addition, it helps combat counterfeit drugs by offering fair pricing that leaves no room for deception! The smart contracts on its permissioned blockchain are explicitly designed to prevent shady actors from accessing sensitive patient details.

Vendor credentialing

Blockchain technology provides rigorous vendor credentialing of drug suppliers to ensure patients receive the best medication quality and safety. This vital step verifies their trustworthiness before any purchases are made — ensuring the drugs they provide meet even health ministry standards.

Buyer assurance

Blockchain technology has given consumers the power to verify a drug’s authenticity with just one scan. Combining QR codes, RFID, and GPS tech makes it easier than ever for companies to identify counterfeit products. As a bonus, buyers can now check product history before purchasing — giving them peace of mind that what they’re getting is genuine merchandise.

Tracing and tracking

Thanks to blockchain technology, supply chain tracing and tracking have reached the next level. The origin of drugs can easily be identified along with a complete list of designated destinations each item is likely to pass through. Software-facilitated decentralization ensures smooth sailing while maintaining high product quality throughout the entire process — now that’s something worth celebrating.

Transparency

By leveraging the public ledger of blockchain tech, all parties have crystal-clear visibility throughout the drug supply chain. So no one needs to worry about a sudden change during transit as everyone involved in the supply process is ‘in the know.’ Everyone has access to essential product information, and any changes during shipping or receiving can be made with a few clicks. With this system in place, counterfeit drugs don’t stand a chance.

Closing Thoughts

The pharmaceutical industry is jumping on the blockchain bandwagon and ushering in a new era of drug serialization that is much more effective than its predecessors. From El Salvador legalizing Bitcoin as a legal tender to World Health Organization giving their support, it’s clear that this groundbreaking technology isn’t going anywhere anytime soon! With features like anonymity, decentralization, tamper-proofing, and transparency, efficient tracking of drugs will help end patient health risks for good.

Comments

All Comments

Recommended for you

  • BTC Surpasses $79,000

    Market data shows that BTC has surpassed $79,000, currently priced at $79,066.69, with a 24-hour decline of 1.91%. The market is experiencing significant volatility, so please ensure proper risk management.

  • BTC Surpasses $79,000

    Market data shows that BTC has surpassed $79,000, currently priced at $79,066.69, with a 24-hour decline of 1.91%. The market is highly volatile, so please ensure proper risk management.

  • Jack Ma Increases Stake, Buying Over HKD 600 Million in Alibaba's Hong Kong Stocks

    According to sources speaking to the Science and Technology Innovation Board Daily on the 25th, as Alibaba initiates a placement financing, Alibaba founder Jack Ma has been continuously increasing his stake in Alibaba's Hong Kong stocks, with the total amount exceeding HKD 600 million, expressing strong confidence in Alibaba's AI prospects.

  • Jack Ma Increases Stake, Buys Over HKD 600 Million in Alibaba Shares

    According to sources speaking to the Science and Technology Innovation Board Daily on the 25th, as Alibaba initiates a placement financing, Alibaba founder Jack Ma has been increasing his stake in Alibaba's Hong Kong shares for several consecutive days, with the total amount exceeding HKD 600 million, expressing strong confidence in Alibaba's AI prospects.

  • BTC Falls Below $79,000

    Market data shows that BTC has fallen below $79,000, currently priced at $78,993.01, with a 24-hour increase of 1.85%. The market is experiencing significant volatility, so please ensure proper risk management.

  • BTC Falls Below $79,000

    Market data shows that BTC has fallen below $79,000, currently priced at $78,993.01, with a 24-hour increase of 1.85%. The market is experiencing significant fluctuations, so please ensure proper risk management.

  • BTC Falls Below $80,000

    Market data shows that BTC has fallen below $80,000, currently priced at $79,983.76, with a 24-hour increase of 3.33%. The market is highly volatile, so please ensure proper risk management.

  • BTC Drops Below $80,000

    Market data shows that BTC has dropped below $80,000, currently priced at $79,983.76, with a 24-hour increase of 3.33%. The market is highly volatile, so please ensure proper risk management.

  • Hyperliquid Policy Center Urges US SEC and CFTC to Adopt Unified Perpetual Contract Framework

    On August 25, the Hyperliquid Policy Center (HPC) submitted comments to the US SEC and CFTC, stating that the two agencies have been striving to find answers regarding the classification of perpetual contracts over the past year. HPC believes that perpetual contracts for stocks, which possess traditional features of futures contracts, can be classified as securities futures. HPC urges the US SEC and CFTC to establish a unified classification system for perpetual contracts, based on the characteristics of each contract and its trading methods, grouping similar products together regardless of whether they reference Bitcoin, crude oil, or individual securities. HPC calls for the US SEC and CFTC to take the following four actions: 1. Confirm that the definition of securities futures includes the established features of futures contracts, allowing cash-settled stock perpetual contracts with these features to be listed as securities futures. 2. Retain the flexibility that trading venues currently have in making product listing decisions. 3. Maintain consistency in classification between the two agencies so that perpetual contracts, regardless of the underlying asset, receive the same threshold classification. 4. Modernize the securities futures framework to revitalize the category and adapt to new product structures.

  • Hyperliquid Policy Center Urges Unified Perpetual Contract Framework from US SEC and CFTC

    On August 25, the Hyperliquid Policy Center (HPC) submitted comments to the US SEC and CFTC, stating that both agencies have been working over the past year to find answers regarding the classification of perpetual contracts. HPC believes that perpetual contracts for stocks, which possess traditional characteristics of futures contracts, can be classified as security futures. HPC urges the US SEC and CFTC to establish a unified classification system for perpetual contracts, based on the characteristics of each contract and its trading methods, grouping similar products together regardless of whether they reference Bitcoin, crude oil, or individual securities. HPC calls for the US SEC and CFTC to take the following four actions: 1. Confirm that the definition of security futures includes the established characteristics of futures contracts, allowing cash-settled stock perpetual contracts with these characteristics to be listed as security futures. 2. Retain the flexibility that trading venues currently have in product listing decisions. 3. Maintain consistency in classification between the two agencies so that perpetual contracts, regardless of the underlying asset, receive the same threshold classification. 4. Modernize the security futures framework to revitalize the category and adapt to new product structures.